Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCOT trial of adjunctive triamcinolone acetonide in vitreoretinal surgery for open globe trauma
2014-002193-37Phase 3Unknown
- Sponsor
- Moorfields Eye Hospital
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone in open globe injury (OGI), Proliferative Vitreoretinopathy (PVR) and retinal detachment (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Dual primary outcome. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
open globe injury (OGI)Proliferative Vitreoretinopathy (PVR)retinal detachment
Beyond the preview
Go deeper on 2014-002193-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002193-37.